Get started
Author

Xia Wu

ORCID: 0009-0004-4099-8626
Observed ORCID: 0009-0004-4099-8626
OpenAlex ID: A5103180301
A derivative of honokiol HM568 has an anti-neuroinflammatory effect in Parkinson's disease
2024 · Changfeng Zhong, Changmei Wang, et al. · Chemico-Biological Interactions · 9
Strategies for Reducing the Homogenization Phenomenon in the Screening of Key Components in Network Pharmacology Based on the Detectability of Components
2025 · Kaiye Peng, Sang Xu, et al. · Rapid Communications in Mass Spectrometry · 3
Non-clinical pharmacokinetics study in rat plasma, tissues and excreta of honokiol derivative HM475 by UPLC-Q-TOF-MS/MS
2023 · Jing Zhang, Wenyuan Li, et al. · Journal of Chromatography B · 3
GC-MS analysis of fatty acid metabolomics in RAW264.7 cell inflammatory model intervened by non-steroidal anti-inflammatory drugs and a preliminary study on the anti-inflammatory effects of NLRP3 signaling pathway
2023 · Lin Chen, Luming Xie, et al. · PLoS ONE · 2
PDF
Exploration of the preliminary mechanism of HM568 in AD treatment: From reverse virtual screening to validation
2026 · Yingjie Liu, Tingyuan Fu, et al. · Letters in Drug Design & Discovery
Comprehensive characterization of Xuebijing injection and comparative analysis of its systemic exposure in patients with severe pneumonia, sepsis, and acute pancreatitis
2025 · Mingxin Guo, Shuo Chen, et al. · Journal of Chromatography Open
Author response for "Strategies for Reducing the Homogenization Phenomenon in the Screening of Key Components in Network Pharmacology Based on the Detectability of Components"
2025 · Kaiye Peng, Sang Xu, et al.
Author response for "Strategies for Reducing the Homogenization Phenomenon in the Screening of Key Components in Network Pharmacology Based on the Detectability of Components"
2025 · Kaiye Peng, Sang Xu, et al.
Works count: 8
Citation count: 17
H-index: 3
I10-index:
Year
Topic
Type